New research on the prevalence and risk factors for new-onset interstitial lung disease (ILD) among individuals with systemic sclerosis who previously tested negative for ILD.
The prevalence and risk factors for new-onset interstitial lung disease (ILD) among previously ILD-negative systemic sclerosis patients are reported in new research presented at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting.
A new article in Arthritis and Rheumatology suggests that extracellular vesicles, which are involved in cell-to-cell communication, may be a factor in the development of fibrosis in systemic sclerosis.
Washington [US], August 27 (ANI): A substance produced by gut microbes may cause scarring and blood vessel damage in scleroderma patients, according to a recent study
Washington [US], August 24 (ANI): A substance produced by gut microbes may cause scarring and blood vessel damage in scleroderma patients, according to a recent study
Michigan [US], August 7 (ANI): During a recent study, a Michigan Medicine researcher discovered a protein that can predict disease severity for a lung condition that often proves fatal for patients with scleroderma.
Michigan [US], August 3 (ANI): During a recent study, researchers discovered a protein that can predict disease severity for a lung condition that often proves fatal for patients with scleroderma.